Filing Details
- Accession Number:
- 0001209191-20-031792
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-22 17:00:12
- Reporting Period:
- 2020-05-21
- Accepted Time:
- 2020-05-22 17:00:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1260990 | Oncternal Therapeutics Inc. | ONCT | Pharmaceutical Preparations (2834) | CA |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1024004 | F David Hale | 12230 El Camino Real, Suite 300 San Diego CA 92130 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-21 | 17,412 | $0.00 | 716,818 | No | 4 | P | Indirect | By Hale BioPharma Ventures LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Hale BioPharma Ventures LLC |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants | Acquisiton | 2020-05-21 | 8,706 | $0.00 | 8,706 | $2.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,706 | 2025-11-21 | No | 4 | P | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 18,346 | Indirect | By Hale Trading Company |
Footnotes
- Pursuant to the Securities Purchase Agreement, dated as of May 19, 2020, by and among the Issuer and the several purchasers party thereto, on May 21, 2020 the Reporting Person purchased the securities reported herein for aggregate consideration $44,792.37.
- The warrants are currently exercisable.
Billionaire Hedge Funds
